Theon Pharmaceuticals Effluent Treatment Plan incorporates a three-stage Reverse Osmosis System. It is designed based on the principles of permeate and reject, considered a universal phenomenon in the RO processes. Know that the three-stage RO system is integral to Theon Pharma’s Effluent treatment plan, each with its specialised function in the treatment process.
The first and foremost stage of our Effluent Treatment plan focuses on the alignment processes following zero liquid discharge requirements (ZLD). ZLD’s main aim is to eliminate any discharge of liquid waste from the industrial processes, ensuring that every effluent is adequately treated and reused/recycled within the system. Process optimisation is the central core, where improvements are made to enhance the overall efficiency and accuracy of the treatment process.
The third and final stage of Theon Pharma’s ETP includes the Mechanical Vapour Recompression (MVR) system. The process involves efficiently handling and treating the eliminated water from the RO stage. The MVR system plays a crucial role in minimising waste and maximising resource utilisation. After seeing the traces of dissolved substances and impurities, the rejected water is finally directed to the MVR system for further purification and recovery.